| Samantha Chevrie Eagle, PT | |
|
4601 Hartford St, Abilene, TX 79605-4603 | |
| (325) 793-3400 | |
| (325) 793-3587 |
| Full Name | Samantha Chevrie Eagle |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 4601 Hartford St, Abilene, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043916901 | NPI | - | NPPES |
| 1227030 | Medicaid | TX | |
| 1227030 | Other | TX | COMMERCIAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1227030 (Texas) | Primary |
| Provider Name | The West Texas Rehabilitation Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922112499 PECOS PAC ID: 2860301215 Enrollment ID: O20120620000597 |
News Archive
MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has filed a clinical trial application (CTA) with the European Medicines and Healthcare products Regulatory Agency (MHRA) seeking clearance to initiate its Phase 1/2 clinical trial using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD).
Researchers from Aalto University have published an article in the recent Trends in Biotechnology journal. The article discusses how DNA molecules can be assembled into tailored and complex nanostructures, and further, how these structures can find uses in therapeutics and bionanotechnological applications.
There are more clinical phenotypes of severe malaria than those defined by the World Health Organization, according to a study led by ISGlobal, an institution supported by "la Caixa" Foundation.
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the quality of its lead product t2c001 has been certified by the European Medicines Agency.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samantha Chevrie Eagle, PT 4601 Hartford St, Abilene, TX 79605-4603 Ph: (325) 793-3400 | Samantha Chevrie Eagle, PT 4601 Hartford St, Abilene, TX 79605-4603 Ph: (325) 793-3400 |
News Archive
MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has filed a clinical trial application (CTA) with the European Medicines and Healthcare products Regulatory Agency (MHRA) seeking clearance to initiate its Phase 1/2 clinical trial using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD).
Researchers from Aalto University have published an article in the recent Trends in Biotechnology journal. The article discusses how DNA molecules can be assembled into tailored and complex nanostructures, and further, how these structures can find uses in therapeutics and bionanotechnological applications.
There are more clinical phenotypes of severe malaria than those defined by the World Health Organization, according to a study led by ISGlobal, an institution supported by "la Caixa" Foundation.
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the quality of its lead product t2c001 has been certified by the European Medicines Agency.
› Verified 6 days ago
Savannah Cox, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2074 Antilley Rd, Abilene, TX 79606 Phone: 325-690-9700 Fax: 325-690-9704 | |
Dr. Martha Rammel Hinman, P.T., ED.D. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Hardin-simmons University, 2200 Hickory, Abilene, TX 79698 Phone: 325-670-5828 Fax: 325-670-5868 | |
Ashley Nicole Bressler, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4601 Hartford St, Abilene, TX 79605 Phone: 325-793-3400 Fax: 325-793-3587 | |
Wendy Anemaet, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4601 Hartford St, Abilene, TX 79605 Phone: 325-793-3400 | |
Russell Dean Mckeever, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3305 N 3rd St, Suite 320, Abilene, TX 79603 Phone: 325-672-6135 | |
Julie Watts, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2074 Antilley Rd, Abilene, TX 79606 Phone: 325-690-9700 Fax: 325-690-9704 | |
Matthew J Mccreary, Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 1633 Cottonwood St, Abilene, TX 79601 Phone: 325-672-4372 |